in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Cerep Signs Deal with Sanofi-Aventis
12:36 PM MST | December 12, 2008 | Chemical Week Editorial Staff
Contract pharmaceutical ingredients manufacturer and pharmaceutical developer Cerep (Paris) says it has signed a drug license agreement with Sanofi-Aventis. The agreement relates to a drug for treating diabetes that was co-developed by the two companies. The drug is currently in pre-clinical trials. The licensing agreement triggers a milestone...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee